Log in to search using one of your social media accounts:

 

New treatment options for common debilitating skin disease Hidradenitis suppurativa
(Trinity College Dublin) The research team behind the study pinpointed 'Th17' cells as mediating the disease (HS). A number of existing treatments target the same cellular pathway and may also be effective in treating HS. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 19, 2017 Category: Biology Source Type: news

Glaswegian woman with lumps in groin thought it was STI
Esme Munro, 35, from Glasgow, mistook the huge, puss-filled lumps for an STI until she was diagnosed  with hidradenitis suppurativa, caused by blocked sweat glands. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2017 Category: Consumer Health News Source Type: news

GRAPHIC IMAGES: Incurable skin condition causes painful abscesses - do you have symptoms?
HIDRADENITIS suppurativa is a painful, long-term skin condition that causes recurring boils and abscesses, usually around the armpits, groin, on the buttocks and under the breasts. (Source: Daily Express - Health)
Source: Daily Express - Health - June 9, 2017 Category: Consumer Health News Source Type: news

Hematological Parameters in Staging Hidradenitis Suppurativa Hematological Parameters in Staging Hidradenitis Suppurativa
What role could hematological markers potentially play in the evaluation of hidradenitis suppurativa?Wounds (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 5, 2017 Category: Pathology Tags: Dermatology Journal Article Source Type: news

Wound Healing and Hidradenitis Suppurativa
(MedPage Today) -- Draining lesions call for specialized attention (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 2, 2017 Category: Primary Care Source Type: news

Hidradenitis suppurativa, intimate partner violence, and sexual assault - Sisic M, Tan J, Lafreniere KD.
BACKGROUND: Sexual assault and intimate partner violence have never been examined in individuals with hidradenitis suppurativa. The research is important, because prior studies show higher incidences of intimate partner violence and sexual assault in indiv... (Source: SafetyLit)
Source: SafetyLit - May 12, 2017 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-s...
Source: Amgen News Release - March 23, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease
NORTH CHICAGO, Ill., Nov. 14, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has gr... Biopharmaceuticals, Dermatology, Regulatory AbbVie, HUMIRA, adalimumab, hidradenitis suppurativa (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2016 Category: Pharmaceuticals Source Type: news

Adalimumab for the Treatment of Hidradenitis Suppurativa Adalimumab for the Treatment of Hidradenitis Suppurativa
Hidradenitis suppurativa is a severe and chronic auto-inflammatory disease, with few therapeutic options, but recent Phase III clinical trials on the efficacy of adalimumab show promise.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 26, 2016 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Humira Partially Effective Against Hidradenitis Suppurativa Humira Partially Effective Against Hidradenitis Suppurativa
The anti-inflammatory drug adalimumab can provide significant relief for about a quarter of people who suffer from a moderate-to-severe case of the chronic skin condition hidradenitis suppurativa, according to two 36-week trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 4, 2016 Category: Consumer Health News Tags: Dermatology News Source Type: news

Clinical trial results support adalimumab treatment for painful skin condition
The results of two phase 3 clinical trials that led to FDA approval of adalimumab for treatment of the chronic inflammatory skin disease hidradenitis suppurtiva are now being published. An inhibitor of the inflammatory protein tumor necrosis factor, adalimumab is the first such medication approved to treat the painful skin disorder. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 4, 2016 Category: Science Source Type: news

Studies highlight diagnostic and treatment challenges in hidradenitis suppurativa
SCOTTSDALE, ARIZ. – Patients with hidradenitis suppurativa (HS) may be misdiagnosed when they see providers who are not dermatologists – as is usually the case during the initial years of their disease, according to a large analysis of medical claims data. The findings highlight the need for... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 3, 2016 Category: Dermatology Source Type: news

Hidradenitis suppurativa and diet: What's recommended?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - July 5, 2016 Category: Consumer Health News Source Type: news

Thousands are too embarrassed about boils to seek help 
Hidradenitis suppurativa, or HS, affects three times as many women as men. Lorraine McPhail, 34, from Cumbernauld, North Lanarkshire, suffers from it. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2016 Category: Consumer Health News Source Type: news

UK NICE recommends Humira as treatment for hidradenitis suppurativa
The National Institute for Health and Care Excellence (NICE) has recommended the use of biopharmaceutical company AbbVie's Humira (adalimumab) for treatment of hidradenitis suppurativa (HS) in adults. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 8, 2016 Category: Pharmaceuticals Source Type: news

Risk of IBD doubled in hidradenitis suppurativa
WASHINGTON – Patients with hidradenitis suppurativa (HS) face an increased risk of also developing inflammatory bowel disease (IBD), Ahuva Cices said at the annual meeting of the American Academy of... (Source: Family Practice News)
Source: Family Practice News - April 4, 2016 Category: Primary Care Source Type: news

Uncontrolled hidradenitis suppurativa costs the health care system
WASHINGTON – One in four hidradenitis suppurativa patients saw their disease become more severe, requiring significantly more health care resources and driving up health care spending. Dr. Alexa Boer Kimball, professor of dermatology at Harvard Medical School, Boston, and her colleagues reviewed... (Source: Skin and Allergy News)
Source: Skin and Allergy News - March 5, 2016 Category: Dermatology Source Type: news

Hidradenitis Suppurativa Tied to Higher MortalityHidradenitis Suppurativa Tied to Higher Mortality
Hidradenitis suppurativa (HS) is associated with a significantly increased risk of adverse cardiovascular (CV) outcomes and all-cause mortality, according to Danish researchers. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 25, 2016 Category: Dermatology Tags: Family Medicine/Primary Care News Source Type: news

Hidradenitis Suppurativa Linked With CV Risks (CME/CE)
(MedPage Today) -- Risks increased for MI, stroke, and cardiovascular death (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - February 17, 2016 Category: Consumer Health News Source Type: news

Hidradenitis suppurativa and risk of adverse cardiovascular events, death
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease marked by painful abscesses that develop in areas where there are large numbers of sweat glands. The disease has been associated with cardiovascular risk factors, such as smoking and obesity, but the risk of cardiovascular disease in patients with HS is unknown. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 17, 2016 Category: Science Source Type: news

Elevated cardiovascular risks linked to hidradenitis suppurativa
The inflammatory skin disease hidradenitis suppurativa is associated with significantly increased risks of adverse cardiovascular outcomes such as ischemic stroke, myocardial infarction, and... (Source: Clinical Neurology News)
Source: Clinical Neurology News - February 17, 2016 Category: Neurology Source Type: news

Elevated cardiovascular risks linked to hidradenitis suppurativa
The inflammatory skin disease hidradenitis suppurativa is associated with significantly increased risks of adverse cardiovascular outcomes such as ischemic stroke, myocardial infarction, and cardiovascular mortality, according to results of a population-based study. A population-based cohort study... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 17, 2016 Category: Dermatology Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only Health Canada Approval for Moderate to Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease MONTREAL, Jan. 6, 2016 (Healthcare Sales & Marketing Network) - AbbVie, a global biopharmaceutical company, today announced that Health Canada approved HUMIRA® (adalimumab)... Biopharmaceuticals, RegulatoryAbbVie, HUMIRA, adalimumab, hidradenitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2016 Category: Pharmaceuticals Source Type: news

Anakinra shows promise for hidradenitis suppurativa
The results of a pilot study suggest that the interleukin-1(IL-1) receptor antagonist anakinra may be a potential treatment option for hidradenitis suppurativa (HS). The cause of HS – a chronic skin disorder affecting areas with apocrine glands leading to nodules, inflammation, rupture, and... (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 1, 2015 Category: Dermatology Source Type: news

Anakinra Shows Promise in Hidradenitis Suppurativa Anakinra Shows Promise in Hidradenitis Suppurativa
Anakinra reduced disease activity in two thirds of patients with hidradenitis suppurativa, although it is unclear how to determine which patients would be most likely to benefit. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 23, 2015 Category: Consumer Health News Tags: Dermatology News Source Type: news

EADV: Hidradenitis suppurativa carries high cardiovascular risk
COPENHAGEN – Hidradenitis suppurativa, a common, chronic, inflammatory scarring skin disease of the hair follicles, is a red flag signaling elevated levels of multiple cardiovascular risk factors, according to a systematic review and meta-analysis.
Source: Skin and Allergy News - October 26, 2015 Category: Dermatology Source Type: news

EADV: Comorbid spondyloarthropathy common in hidradenitis suppurativa
COPENHAGEN – Back pain is surprisingly common in patients with hidradenitis suppurativa, and more than half of affected patients showed MRI evidence of axial spondyloarthropathy, Dr. Sylke Schneider-Burrus reported at the Annual Congress of the European Academy of Dermatology and Venereology.... (Source: Skin and Allergy News)
Source: Skin and Allergy News - October 22, 2015 Category: Dermatology Source Type: news

New FDA approval for adalimumab: Hidradenitis suppurativa
The approval of adalimumab has been expanded to include the treatment of moderate to severe hidradenitis suppurativa. Approval is based on the results of two phase III studies, PIONEER Iand
Source: Skin and Allergy News - September 24, 2015 Category: Dermatology Source Type: news

FDA Clears Adalimumab (Humira) for Hidradenitis SuppurativaFDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa
The TNF blocker becomes the first and only FDA-approved agent for treatment of moderate to severe hidradenitis suppurativa. Orphan Drug Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 11, 2015 Category: Dermatology Tags: Dermatology News Alert Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease FDA granted HUMIRA orphan drug designation for moderate to severe HS (Hurley Stage II and Hurley Stage III disease) in May NORTH CHICAGO, Ill., Sept. 10, 2015 -- (Healthcar... Biopharmaceuticals, Dermatology, FDAAbbVie, hidradenitis suppurativa, HUMIRA, adalimumab) (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2015 Category: Pharmaceuticals Source Type: news

AbbVie receives European approval for Humira to treat hidradenitis suppurativa
AbbVie has received approval from the European Commission (EC) for its Humira (adalimumab) to treat moderate-to-severe hidradenitis suppurativa (HS or acne inversa), which is a painful and chronic inflammatory skin disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 30, 2015 Category: Pharmaceuticals Source Type: news

Hidradenitis Suppurativa: Acne Inversa - Causes, Symptoms & Treatment
Hidradenitis suppurativa is a form of chronic skin condition featuring pea-sized to marble-sized lumps underneath a person's skin. The condition is also known as, 'acne inversa,' and deep-seated lumps commonly develop where a person's skin rubs together, such as in the groin area, armpits, underneath breasts or between buttocks. The lumps associated with hidradenitis suppurativa are often times painful and might break open and drain bad-smelling pus. (Source: Disabled World)
Source: Disabled World - July 8, 2015 Category: Disability Tags: Skin Conditions Source Type: news

Weekly adalimumab at 40 mg works best for hidradenitis suppurativa
SAN FRANCISCO – Weekly treatment with 40 mg of adalimumab yielded the strongest clinical responses in adults with moderate to severe hidradenitis suppurativa with a safety profile similar to less intensive doses, according to data from two phase III trials. Overall, 43% of adalimumab-treated... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 1, 2015 Category: Dermatology Tags: SAN Conference News IMN Dermatology IMN News SAN Clinical News SAN News SAN Acne & Rosacea American Academy of Dermatology Source Type: news

Bacteria in Hidradenitis Suppurativa Support Antibiotic UseBacteria in Hidradenitis Suppurativa Support Antibiotic Use
Bacteria known to cause skin and soft tissue infections were uncovered in microbiological studies of the skin disease hidradenitis suppurativa. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2014 Category: Consumer Health News Tags: Dermatology News Source Type: news

Abbvie's Phase III trial of Humira meets primary endpoint
AbbVie has reported positive results from a Phase III pivotal trial, which was designed to evaluate the investigational use of Humira (adalimumab) in patients with moderate-to-severe hidradenitis suppurativa (HS). (Source: Drug Development Technology)
Source: Drug Development Technology - September 14, 2014 Category: Pharmaceuticals Source Type: news

Hidradenitis Suppurativa Prevalence in the United StatesHidradenitis Suppurativa Prevalence in the United States
While clinical diagnosis of hidradenitis suppurativa is rare, its prevalence is widely cited as approximately 1%. What's the real figure? American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2014 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Fast Hidradenitis Suppurativa Cure Review: Secrets and Benefits of...
Fast Hidradenitis Suppurativa Cure designed by Therese Wilson is the latest program that helps people relieve their HS symptoms quickly and easily without using any medication. A detailed Fast...(PRWeb December 31, 2013)Read the full story at http://www.prweb.com/releases/fast-hidradenitis/suppurativa-cure/prweb11454961.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 1, 2014 Category: Pharmaceuticals Source Type: news

Fast Hidradenitis Suppurativa Cure Review Exposes a Unique HP...
Findreviewtoday.com reviews one of the newest and unique ways to manage Hidradenitis Suppurativa: Therese Wilson’s Fast Hidradenitis Suppurativa Cure. This guide book promises a natural and effective...(PRWeb October 11, 2013)Read the full story at http://www.prweb.com/releases/fast-hidradenitis/suppurativa-review/prweb11222252.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 14, 2013 Category: Pharmaceuticals Source Type: news

Immunosuppression and Retinoids in Hidradenitis SuppurativaImmunosuppression and Retinoids in Hidradenitis Suppurativa
This review evaluates current evidence for the use of systemic immunosuppressive agents and retinoids for treatment of the chronic inflammatory skin disease hidranenitis suppurativa. The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 25, 2013 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news